期刊文献+

四例儿童胰腺脂肪替代的CT表现及文献复习

原文传递
导出
摘要 胰腺脂肪替代(fattyreplacementofpancreas)又称为脂肪过多症(1ipomatosis)、脂肪浸润(fatinfiltration)、多脂肪性萎缩(adiposeatrophy),是脂肪细胞在胰腺实质内的堆积。国外也有学者将由于脂肪组织替代造成胰腺体积增大称为脂肪瘤样假性肥大(1ipomatouspseudohypertrophy)。成年人胰腺不均匀脂肪替代常与肥胖和年龄有关;而在儿童,囊性纤维化是胰腺脂肪替代最常见的原因。儿童胰腺脂肪替代在国内报道极少,国外报道较多,主要由于囊性纤维化好发于欧洲白种人,极少发生于亚洲人种。
出处 《中华放射学杂志》 CAS CSCD 北大核心 2013年第3期263-265,共3页 Chinese Journal of Radiology
  • 相关文献

参考文献10

  • 1Matsumoto S, Mori H, Miyake H, et al. Uneven fatty replacement of the pancreas : evaluation with CT. Radiology, 1995,194:453-458.
  • 2Robertson MB, Choe KA, Foseph PM. Review of the abdominal manifestations of cystic fibrosis in the adult patient. Radiographics, 2006,26:679-690.
  • 3Vaughn DD, Jabra AA, Fishman EK. Pancreatic disease in children and young adults: evaluation with CT. Radiographics, 1998,18 : 1171-1187.
  • 4宋彬,李兆申.胰腺囊性纤维化研究进展[J].胰腺病学,2005,5(2):126-128. 被引量:2
  • 5Nijs E, Callahan MJ, Taylor GA. Disorders of the pediatric pancreas: imaging features. Pediatr Radiol,2005 ,35 :358-373.
  • 6Soyer P, Spelle L, Pelage JP, et al. Cystic fibrosis in adolescents and adults: fatty replacement of the pancreas. CT evaluation and functional correlation. Radiology, 1999,210:611-615.
  • 7李迎春,宋彬,徐隽,杨洋,印隆林.胰腺脂肪替代的CT表现及临床意义(附3例报告)[J].中国普外基础与临床杂志,2006,13(6):724-728. 被引量:5
  • 8Fields TM, Michel SJ, Butler CL, et al. Abdominal manifestations of cystic fibrosis in older children and adults. AJR Am J Roentgenol, 2006,187 : 1199-1203.
  • 9Durie PR. Inherited causes of exocrine pancreatic dysfunction. Can J Gastroenterol, 1997,11 : 145-152.
  • 10Augarten A, Ben Tov A, Madgar I, et al. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype. Eur J Gastroenterol Hepato1,2008,20 : 164-168.

二级参考文献20

  • 1YuanLi,LeiCao,BaozhiWang,ShurongLi,GuishengLiu.The structural change of pancreatic tissue of fatty rats induced with high-fat food and its pathological significance[J].中国组织化学与细胞化学杂志,2004,13(3):353-354. 被引量:2
  • 2Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, 1989, 245: 1066-1073.
  • 3Zeitlin PL. Novel pharmacologic therapies for cystic fibrosis. J Clin Invest, 1999,103:447-452.
  • 4Khan TZ, Wagener JS, Bost T, et al. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med, 1995, 151:1075-1082.
  • 5Katz DP, Manner T, Furst P, et al. The use of an intravenous fish oil emulsion enriched with omega-3 fatty acids in patients with cystic fibrosis. Nutrition, 1996, 12:334-339.
  • 6Freedman SD, Kern HF, Scheele GA. Pancreatic acinar cell dysfunction in CFTR(-/-) mice is associated with impairments in luminal pH and endocytosis. Gastroenterology, 2001, 121:950-957.
  • 7Dooley RR, Guilmette F, Leubner H, et al. Cystic fibrosis of the pancreas with varying degrees of pancreatic insufficiency. Am J Dis Child, 1956,92:347-368.
  • 8Schwachman H. Gastrointestinal manifestations of cystic fibrosis. Ped Clin N Am, 1975, 22:787-805.
  • 9Kerem E, Corey M, Kerem BS, et al. The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (△F508). N Engl J Med, 1990, 323:1517-1522.
  • 10Cade A, Walters MP, McGinley N, et al. Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis. Pediatr Pulmonol,2000,29 : 172-176.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部